Cardiovascular Events in Renal Transplant Recipients With Low LDL-Cholesterol Receiving Tacrolimus in Combination With the Statin Fluvastatin.
Phase of Trial: Phase II/III
Latest Information Update: 05 Aug 2011
At a glance
- Drugs Fluvastatin (Primary) ; Tacrolimus
- Indications Cardiovascular disorders; Renal transplant rejection
- Focus Therapeutic Use
- 05 Aug 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 05 Aug 2011 Planned End Date changed from 1 Apr 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 09 Nov 2005 New trial record.